Testosterone Pellets vs Cream: Which Can You Stop More Easily?

Testosterone pellets vs cream is a choice between less daily work and more dose flexibility. Pellets require an implant and usually work for three to four months. A clinician can change a cream regimen more readily, but there is no verified two-day washout rule for compounded cream. Testopel is FDA-approved; compounded cream is not. Testopel labeling; AndroGel 1.62% labeling; FDA compounding guidance.

Last verified: September 2026 — checked 21 September 2026 · By TRT Provider Guide · Educational information, not medical advice. No clinician reviewed this page.

Cream may fit your preferences if: avoiding a procedure and being able to discuss changes to a future prescription matter more than avoiding a daily routine. That does not make cream the right starting treatment for everyone.

Pellets may fit your preferences if: less daily treatment work matters most, you accept an in-person procedure, and you understand the longer dose commitment. There is no evidence-based rule in the sources reviewed that you must first be stable on testosterone for one year.

Neither one yet if: low testosterone has not been properly evaluated with symptoms or signs and consistently low results, including appropriate repeat morning testing; you are trying to conceive now or soon; or a concerning blood count, blood pressure, prostate finding, or health history still needs evaluation. Those are clinician questions, not reasons to default to cream. Endocrine Society guideline.

Disclosure: Male Excel is a disclosed affiliate partner of TRT Provider Guide. We may earn a commission when readers use our affiliate links. FDA-approved gel and pellet care are included because they belong in this decision, not because of whether a provider pays us. Read our affiliate disclosure.

Testosterone pellets vs cream: what does the side-by-side show?

Pellets and cream differ most in treatment commitment, daily work, and product status. There is no reliable basis in the evidence reviewed to say that one gives every man better symptom relief, fewer overall risks, or a lower complete annual bill.

Sources: Testopel prescribing information, AndroGel 1.62% prescribing information, FDA compounding guidance, and Aetna's Testopel policy. Gel-specific findings below are not treated as measured results for compounded cream.

The three-line version: if being able to change treatment matters most, discuss a topical option. If daily treatment is the obstacle and you accept the longer commitment, pellets earn a place in the discussion. If FDA approval is your priority, Testopel remains an option, and an FDA-approved gel is the nonprocedural alternative to ask about.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

What's actually being compared here?

This page compares implanted testosterone pellets with prescription compounded testosterone cream for U.S. adult men being evaluated or treated for testosterone deficiency. FDA-approved testosterone gel appears as an alternative because cream and gel are not interchangeable product categories. FDA testosterone information; FDA compounding guidance.

The pellet, in plain terms. The FDA-approved product is Testopel. Each pellet is about 3.2 mm wide and 9 mm long and contains 75 mg of testosterone plus two inactive ingredients. A clinician places the pellets under the skin during a procedure. They release testosterone over time; there is nothing to apply each day. Compounded pellets also exist, so the word “pellet” alone does not identify the product. Testopel prescribing information.

The cream, in plain terms. A compounding pharmacy makes the cream at the strength your prescriber writes. The prescription determines how much, how often, and where it is applied. Do not borrow an approved gel's directions or another patient's cream instructions: the formula and application site affect exposure. FDA compounding guidance; scrotal cream pharmacokinetic study.

One scope note: this page is about adult men. Testosterone dosing, targets, and risks for women are a different clinical question with different evidence, and nothing here should be applied to a woman's care. This is also not a dosing guide for adolescents, gender-affirming care, or performance enhancement.

The real difference: which one can your clinician change or stop?

A topical prescription is easier to change because it does not leave an implanted supply of testosterone under the skin. But the 48-to-72-hour return-to-baseline figure comes from AndroGel 1.62%, not from compounded testosterone cream. Testopel's label warns that implantation is much less flexible for dose adjustment and that stopping its effects may require removing pellets. AndroGel 1.62% labeling; Testopel labeling.

Here's what the labels actually establish—and what they do not.

Two things in that table deserve a second look.

The label itself says pellets are hard to adjust. That isn't a competitor's talking point. It's in the PRECAUTIONS section of Testopel's FDA label, which also warns clinicians to use "great care" estimating the dose for exactly that reason. Testopel prescribing information, Precautions.

The release is front-loaded. A pellet doesn't drip out evenly. The Testopel label estimates roughly one-third of the material is absorbed in month one, one-quarter in month two, and one-sixth in month three. That is a label-described pattern, not a promise that every patient's blood level peaks on a particular day. Testopel prescribing information, Dosage and Administration.

Why “stopping” isn't hypothetical

A rising blood count, a blood-pressure change, a prostate finding that needs assessment, or a lack of benefit can change a treatment plan. The Endocrine Society recommends follow-up to check response, adverse effects, and whether the patient is using treatment as intended. A clinician—not the delivery format—decides how to handle a problem. Endocrine Society guideline; AndroGel 1.62% warnings.

One insertion can still be releasing testosterone while you and your clinician are deciding whether the treatment is working for you. That is the practical cost of the convenience. With pellets, do not accept “we'll just wait until the next insertion” as the only explanation of how the clinic handles a significant adverse effect.

Can you switch later?

A clinician can plan a switch, but the timing isn't even. A pellet-to-topical switch has to account for testosterone still being released by the implant; starting another format on top of it is not a do-it-yourself decision. A cream-to-pellet switch also needs a clinical plan rather than a guaranteed “next appointment” timetable. Testopel prescribing information; Endocrine Society guideline.

If you already suspect you'll want out, ask that question before the insertion, not after.

If flexibility matters more to you than avoiding a daily routine, compare the topical product and the program separately. See our Male Excel cost breakdown and the charges to confirm →

How many pellets are involved—and why does that affect the bill?

Pellet count matters only when you also know the strength of each pellet. Testopel contains 75 mg per pellet, but a count quoted for another product is not automatically comparable. The following numbers describe labeling and published studies; they are not a starting dose or a target for you. Testopel prescribing information.

We put the label, two clinical cohorts, and the payment question in one place so you can see where the numbers come from.

Sources: Testopel label, McCullough et al., Pastuszak et al., and Aetna policy. The pellet equivalents in the first row are simple division by 75 mg.

Now look at what that means for your wallet and your bloodwork. Some counts studied in clinical practice exceed the label's stated dosage guidance. That deserves an explanation from the prescriber, not an assumption that the larger number is automatically better. Published cohort findings are not a substitute for that discussion.

What to do with this: ask for your dose in milligrams, not in pellets. Get the product name, strength per pellet, count, total milligrams, and expected treatment interval. Then ask what number of covered units your plan approves, before the appointment.

For a cash quote, ask whether the clinic charges by pellet, by procedure, or by package. A package price and a per-pellet price need different math; neither tells you the complete cost until the included visits and labs are listed.

Is testosterone cream FDA-approved?

The compounded testosterone creams discussed here are not FDA-approved. FDA-approved gels and Testopel pellets are separate options; FDA approval does not rule pellets out. FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. FDA compounding guidance; Testopel label; AndroGel 1.62% label.

This is where comparison pages can quietly swap “cream” and “gel” as if they're the same word. They are not the same regulatory category.

Sources: FDA testosterone information, FDA compounding guidance, and Testopel labeling.

The part that doesn't help us

Male Excel's cream is compounded, not an FDA-approved testosterone product. Its commercial relationship with this site does not change that. Male Excel states the compounded status on its own treatment page; the regulatory distinction comes from the FDA. Male Excel cream information; FDA compounding guidance.

FDA explains that compounded medicines can meet a patient's medical need when an approved drug cannot. That is a reason to ask why this specific compounded product is needed for you, not a reason to treat “custom” as proof of better care. An approved testosterone product can also have a dose adjusted around clinical response and lab results. FDA compounding guidance; AndroGel 1.62% labeling.

Pellets don't have that problem — at least Testopel doesn't. It's a real approved drug with a label you can read. A compounded pellet is a different category, so ask which product the clinic plans to implant. Testopel label; FDA compounding guidance.

If FDA approval is your single highest priority, ask about Testopel or an approved topical gel—not compounded cream. A retail-pharmacy gel quote belongs in the comparison, but it is not automatically the cheapest complete care route. The exact product, quantity, insurance, pharmacy, visits, and labs determine that bill.

For that narrower decision, see testosterone cream vs gel.

Why an application site does not prove a cream is better

AndroGel 1.62% has product-specific application instructions for the shoulders and upper arms. Those instructions do not apply to every approved gel or every cream. AndroGel 1.62% label.

A 2017 study tested single scrotal applications of testosterone cream in healthy men whose testosterone had been experimentally suppressed. Testosterone rose in a dose-dependent way and peaked roughly two to three hours after application; DHT, a hormone formed from testosterone, also rose. This was a short pharmacokinetic study—how the drug moves through the body—not a pellet-versus-cream trial or proof of better symptoms, long-term safety, or two-day reversibility. It did not study inner-thigh application. Iyer et al., 2017.

The trade is not “an FDA label versus a dose built around your labs.” Both approved and compounded treatment need a clinical plan. The real questions are why this product is being proposed, how its quality is controlled, what evidence applies to it, and what happens if it needs changing.

That's a real trade with a real cost on both sides. Make it with your eyes open.

Does “not FDA-approved” mean the cream is illegal?

No. Federal law provides pathways for compounding when their conditions are met. Section 503A generally concerns compounding for identified patients, while section 503B provides a different framework for registered outsourcing facilities. Neither pathway turns the compounded drug into an FDA-approved finished product, and neither is a blanket exemption from legal requirements. FDA compounding guidance.

That's why the questions below matter more for a cream than for a gel.

What to ask if a clinic offers you cream

• Is this compounded, or an FDA-approved product?
• Which pharmacy makes it, and what strength is it, in milligrams per gram?
• Why this instead of an approved gel, for me specifically?
• Exactly where do I apply it, and what precautions come with that site?
• What monitoring is included, and how often?
• What happens if the formula needs to change?

One provider-specific conflict to settle before a prescription is filled: Male Excel's cream FAQ names the scrotum or inner thigh, while safety text on its public pages names shoulders, upper arms, and abdomen. These are different directions. We did not choose between them or assume that either applies to your prescription. Get instructions from the prescribing clinician and dispensing pharmacy that agree on the actual product and application site. Male Excel cream page; Male Excel pricing-page safety text.

If your clinician has explained why compounded cream fits your situation, the next step is checking the actual program—not assuming that “custom” means better. Read our Male Excel profile and the questions to settle before paying →

Does testosterone cream really transfer to your wife or kids?

Topical testosterone can expose another person through skin contact. The often-quoted 280% and 6% figures were measured in separate AndroGel 1.62% studies, not in a compounded-cream study. Pellets avoid this particular topical exposure pathway, but that does not make them safer overall for every patient. AndroGel 1.62% labeling; Testopel labeling.

Here are the numbers with the product, population, and limits left attached.

Source: AndroGel 1.62% prescribing information, Clinical Pharmacology: potential for transfer, hand washing, and showering. These study details explain the evidence; they are not application or dosing instructions.

What the boxed warning is actually about. Approved testosterone gel labeling describes real post-marketing reports: children exposed second-hand developed signs of virilization, including enlarged genitals, pubic hair, and advanced bone age. In most reported cases the signs went away once the exposure stopped. In a few, they did not fully reverse. That's the honest version—not a scare, and not a shrug. AndroGel 1.62% boxed warning and Warnings and Precautions.

And the honest counterweight: covering the site and washing reduce transfer; they are not a guarantee that the problem is solved. Follow the precautions for the exact prescription and ask the pharmacist what to do after possible accidental contact. Do not copy a gel's instructions onto a different cream.

One limit you should know about. Those numbers come from an approved gel. We did not establish matching transfer measurements for the specific compounded creams and application sites discussed here. Different site, different clothing coverage, different formula. So don't assume the gel's numbers carry over exactly, and don't assume a cream's instructions match a gel's. Ask your prescriber and your pharmacy what precautions apply to your product and your application site, in writing.

Who needs a different discussion before choosing cream: if you have a toddler who climbs on you, a pregnant partner, or regular skin-to-skin contact that makes the precautions impractical, tell your clinician before treatment. A non-topical format avoids transfer from a topical application site, but its other risks still need to be weighed. Trying to conceive also raises a separate fertility issue with every testosterone format.

If transfer precautions do fit your household, the next question is whether the program's product and follow-up fit you too. Review Male Excel's offering and the details to confirm →

What does each one actually cost in your first year?

There is no verified national all-in price that makes pellets or cream the automatic winner. Male Excel's two public pricing pages list different charges, and six 60-day medication orders cover 360 days, not a full 365-day year. Compare the written billing schedule as well as the advertised monthly figure. Main pricing page; alternate pricing page.

We checked the pages below on 21 September 2026. These are provider-stated prices and explicitly labeled calculations, not a completed checkout, a personal prescription quote, or a promise that either package will be offered to you.

Sources: Male Excel main pricing, Male Excel alternate pricing, and Aetna's Testopel coverage and coding policy. All arithmetic assumes unchanged prices and an unchanged prescription. Taxes, additional testing, visits not included in the offer, and treatment changes can alter the bill.

The 360-day versus 365-day catch

Under the alternate page's literal schedule, assume the first medication order and membership charge occur on treatment day 0, with uninterrupted billing afterward. Orders on days 0, 60, 120, 180, 240, 300, and 360 mean seven medication orders during the first 365 days; membership on days 0 through 360 every 30 days means thirteen membership charges.

That cash-payment scenario is $2,092:

$99 + 7 × ($150 cream + $59 thyroid + $20 shipping) + 13 × $30 membership = $2,092.

The last order includes medicine for days beyond the first year. This is a transparent billing example, not a verified quote or a claim that you will use seven full supplies within one year. Billing start dates, calendar-month versus 30-day membership, the actual prescription, and whether the offer applies to you must be confirmed. Published inputs: alternate pricing page.

The same distinction affects the main page. If “60 days” means literal 60-day orders at $264 per order, while membership is charged twelve times in the first calendar year, the corresponding illustrative cash total is $3,135 before shipping and other unlisted costs: $99 + 7 × $264 + 12 × $99. If the provider instead uses calendar-month billing, the schedule changes. The page's wording alone does not settle that.

Three things worth pulling out of those prices

Something is bundled you may not have asked for. Male Excel's headline cream price includes thyroid tablets in the same package. Ask the prescriber why any second medicine is indicated and ask what the testosterone alone costs. A bundle is a price structure, not proof that you need both medicines. Main pricing page; alternate pricing page.

The same company publishes two different membership fees. On maleexcel.com, the required Medical Membership is listed at $99/month. On hrt.maleexcel.com, the Concierge Medical Membership is listed at $30 every 30 days. Both pages were live when checked. We could not establish from those pages which offer applies to a new patient; we are not presenting their difference as guaranteed savings. Main pricing; alternate pricing.

Even the alternate page disagrees with itself on one line. Its cream-package summary lists thyroid at $59, while its detailed thyroid section lists $60. The calculations above use the $59 summary price; using $60 adds $6 to the six-order example or $7 to the seven-order example. The same page lists cream at $2.50 per gram, but the actual prescription determines the amount required. Alternate pricing page.

So do this: before your first charge posts, get your total recurring charge and billing interval in writing in the patient portal—medication, membership, and shipping, together. Ask for the dates and amounts of the first year of charges, plus any separate labs or visits. Keep the answer; a verbal estimate is harder to compare later.

And on pellets: ask two questions: “What's your medication price, and is it per pellet or a package?” and “What's your insertion fee?” Then ask how many procedures, visits, and lab draws the estimate assumes. A clinic may be able to quote a package or range before labs even though a final treatment plan requires evaluation.

If you want the cream number settled before you commit, compare all the components—not the headline price. See our Male Excel cost guide and the questions to resolve before your first charge →

Does insurance cover pellets or cream?

Testopel has an insurance-billing pathway, but coverage depends on the plan, diagnosis, documentation, and treatment requested. Compounded cream coverage is plan-specific, and a provider that does not accept insurance is a separate issue from whether a pharmacy benefit covers a particular medicine. Male Excel describes its service as cash-pay rather than insurance-billed. Aetna Testopel policy; Male Excel terms.

The code is not the same thing as coverage

Aetna's published Testopel policy lists J1073, a testosterone pellet drug unit per 75 mg, and CPT 11980 for implantation. Those codes identify services; they do not guarantee payment or make the same coverage rule apply to every plan. Aetna policy, CPT and HCPCS codes.

The Medicare document often cited here is retired. CMS article A55057 has a retirement date of 6 November 2025. It is not a current nationwide Medicare coverage promise. Ask the clinic to check the active policy for your Medicare contractor or your Medicare Advantage plan rather than relying on that retired article. CMS A55057 record.

Before an insertion, ask about authorization, covered units, cost sharing, and who is responsible for any noncovered charge. Do not assume that every additional pellet is automatically billable to you, that every insurer has the same pellet cap, or that an appeal can only happen before treatment.

The “age-related” issue changed in 2026—but your plan may not have

Older testosterone labeling says safety and effectiveness for age-related hypogonadism have not been established. On 18 June 2026, FDA announced that it was requesting removal of that limitation, along with other labeling updates. That request is not proof that every product label or insurance policy had already changed by the audit date. HHS/FDA announcement.

Aetna's published Testopel policy reviewed for this page still excludes age-related hypogonadism. That is a specific payer example, not a statement about every insurer. Ask which policy and documentation your plan is applying to your case. Aetna policy.

If you're going the insurance route, ask your clinic to run a pre-service check on the pellet count they plan to use. If you're going cash-pay, ask your plan administrator which charges qualify for HSA or FSA reimbursement; a program's “eligible” label does not settle every charge or every account rule.

What actually goes wrong with pellets: infection, extrusion, or something else?

Pellet extrusion—a pellet working its way back out through the skin—and infection are documented complications. Published studies differ in patients, products, follow-up, and technique, so their percentages are not a single national risk estimate or proof that one operator or brand is best. Cream avoids an implantation wound, but its risks are not limited to mild skin irritation. Testopel labeling; Cavender and Fairall; AndroGel 1.62% labeling.

Sources: Cavender & Fairall, 2009, McCullough et al., 2012, and Testopel Warnings. The calculated multicenter percentages are 4 ÷ 702 and 3 ÷ 702, rounded to one decimal percentage point.

Both the product and the person doing the insertion matter. These studies do not establish that insertion technique matters more than pellet identity. Ask the clinician: How many of these have you done? Which product and technique do you use? What happens—and what does it cost me—if one extrudes or gets infected?

For cream, the practical annoyances include measuring, applying, allowing it to dry as directed, and managing contact with other people. Skin irritation is possible, but a high testosterone exposure, blood-count change, blood-pressure increase, or secondary exposure is not automatically mild or immediately reversible. Gel trial percentages should not be passed off as the measured complication rate of an unspecified compounded cream. AndroGel 1.62% labeling; FDA compounding guidance.

What's actually inside the pellet?

Testopel contains 75 mg of testosterone plus two inactive ingredients: stearic acid and povidone. A compounded pellet is a different finished product, so do not assume the same strength, ingredients, or manufacturing evidence. Get the label and dispensing facility's name before the procedure. Testopel labeling; FDA compounding guidance.

Sources: Testopel labeling and FDA compounding guidance.

If another active medicine is part of an implant, ask why it is being used, how long it is expected to act, and how an adverse effect would be managed. Do not accept a routine bundle as the explanation. The name and amount of every medicine belong in your records.

The 2026 Asteria recall makes the supplier question concrete

On 26 January 2026, Asteria Health, a Biote subsidiary, announced a voluntary recall of specified hormone-pellet lots because of the potential presence of metal particulate matter. Biote's 2026 regulatory filing confirms the recall and continuing supply effects. This is a specific supplier-and-lot issue, not evidence that all pellets or Testopel were recalled. Biote second-quarter 2026 Form 10-Q, Inventory and Voluntary Recall sections.

The filing itself gives two slightly different shipment end dates: 19 January 2026 in its inventory note and 20 January 2026 in its operating discussion; both start at 20 May 2025. That is another reason to have the clinic check the actual lot record rather than decide from a date range alone. Biote Form 10-Q.

So ask, plainly and without accusation: Which facility makes your pellets, what lot did you receive, and does a recall affect it? Ask for the answer in your medical record. Supplier traceability matters before there is a problem, not just after one.

Fertility: what should you settle before picking a format?

Testosterone from outside your body — in any format — can shut down sperm production, and the effect may not be reversible. If children are on your horizon, the delivery format is the wrong question to be asking. AndroGel 1.62% labeling, Infertility; Endocrine Society guideline.

The Endocrine Society recommends against starting testosterone in men planning fertility in the near term. Discuss this before a cream prescription or pellet insertion, not as an optional add-on after treatment starts. Endocrine Society guideline.

Here's where the format does still matter: a prescriber can change future topical applications without leaving an implant in place. That does not mean sperm production recovers in 48–72 hours, or on any guaranteed timetable. The approved gel's serum-testosterone washout is a different measurement from fertility recovery. AndroGel 1.62% labeling, Pharmacokinetics and Infertility.

A fertility-aware specialist may discuss approaches other than exogenous testosterone. Those are not interchangeable with TRT, and their approval status, evidence, and monitoring need to be assessed for the actual medicine and indication. No clinic should call an alternative “natural TRT” or promise that it will protect or restore fertility.

If fertility is on the table in the next few years, start with a urologist or reproductive urologist, not a delivery format. Read our TRT and fertility guide or use Find My TRT Path to organize the care-route questions before you pay.

Why is the blood-count problem also a treatment-flexibility problem?

Testosterone can raise hematocrit—the share of your blood made up of red cells—and an elevated result can require a clinician to pause or change treatment. Pellets make that decision less flexible because testosterone is still being released under the skin. But a topical prescription does not make an elevated blood count normalize immediately. AndroGel 1.62% labeling, Polycythemia; Testopel labeling.

The approved gel's label calls for checking hematocrit before treatment, again at three to six months, and then annually. That is not the whole monitoring plan: testosterone levels, symptoms, blood pressure, adverse effects, and other indicated tests also need follow-up, with timing tailored to the product and the patient. AndroGel 1.62% labeling; Endocrine Society guideline.

The takeaway: whichever format you pick, get the monitoring schedule in writing before you pay. If you pick pellets, ask what the clinic's plan is if your hematocrit runs high in month two.

What changed in the FDA's safety information?

In February 2025, FDA announced removal of the older boxed-warning language about increased adverse cardiovascular outcomes, following its review of the TRAVERSE trial, and required blood-pressure information based on additional studies. That did not remove the topical gel's boxed warning about secondary exposure. FDA's February 2025 announcement; current AndroGel 1.62% labeling.

The clinical trial discussed in that announcement studied an approved testosterone gel in a defined population. It does not establish that every cream, pellet, dose, or patient has the same risk. “The FDA removed the boxed warning on testosterone” leaves out which warning changed and which did not.

In June 2026, FDA also requested changes to the age-related limitation and prostate-related labeling. Those were requested revisions, not a reason to ignore symptoms, skip monitoring, or treat a history of prostate cancer as an online self-clearance question. The product's current label, the person's history, and an appropriate clinician's assessment still matter. HHS/FDA June 2026 announcement.

What does each one look like on an ordinary Tuesday?

Pellets concentrate the work into a few clinic visits a year. Cream spreads it across every day. Neither is objectively easier — the question is which inconvenience you'll actually live with twelve months from now.

If you choose pellets: most Tuesdays, no topical application. No measuring or drying time for this treatment. Insertion and follow-up visits still have to happen, and recovery instructions come from the clinician. You'll still need lab work. Testopel labeling; Endocrine Society guideline.

If you choose cream: your routine follows the prescription. Male Excel describes twice-daily use on its public cream page, but that is not a universal schedule for every product. Think about it before the gym, before bed, before anyone touches the application site. There is no implantation wound to heal from, but there are still monitoring appointments and prescription questions to manage. Male Excel cream page; Endocrine Society guideline.

Be honest about which of those two descriptions made you wince. Then take that preference to the clinical discussion; convenience does not overrule fertility plans, contraindications, or a monitoring problem.

Who should discuss pellets rather than cream?

Pellets deserve a discussion when the daily routine is a real obstacle, avoiding topical transfer matters, and the patient accepts an in-person procedure and a longer treatment commitment. That is a preference-based fit, not a finding that pellets are the safest or most effective option for every man with children at home. Proper evaluation and a plan for adverse effects come first. Testopel labeling; Endocrine Society guideline.

If that's you, here's how to do it well.

• Find the right clinician and identify the product. Ask about relevant experience, qualifications, and follow-up—not just the pellet brand.
• Ask about Testopel by name, and ask what changes if the clinic proposes a compounded pellet instead—strength, ingredients, and who makes it.
• Get the pellet count and milligram total in writing, and run the insurance pre-check on that count.
• Take the question list below with you. The six pellet questions on it are the ones that can change the decision.

This page does not send you to a pellet clinic's enrollment form. It still includes pellets because leaving out a suitable care route would make the comparison less useful.

If you read that and realized cream is your format after all, that's the section above. If you read it and realized you're not sure testosterone therapy is even the right call yet, start with Find My TRT Path instead of either one.

What should you take with you before paying?

A written quote and treatment plan make these formats easier to compare before money changes hands. These twelve questions are the ones that change the answer. A portal message or an email counts. Ask for a written copy of a verbal answer so you can compare it later.

Ask the pellet clinic

Ask the cream program

For either care route, also settle the basics: who orders and pays for repeat diagnostic testing, which clinician manages treatment, how you reach that clinician, how adverse results are handled, and how you obtain your records. Ask separately about canceling medication renewals, canceling membership, and refund eligibility. One answer may not cover all three.

And your own cost worksheet

Clinic quotes aren't comparable until they're built the same way. Fill this in with the numbers they give you — not ours. Blank cells are for your own quotes; the worksheet does not assume any fee is zero.

Use the same formula for both: initial fees + medication payments + procedure fees + membership payments + separate labs and visits + shipping + applicable taxes. For insured care, use your expected patient responsibility rather than adding the insurer's payment to your own bill. Show prepaid supplies separately so a payment-year total is not confused with a year's consumption.

If a clinic won't fill in a row, that row is the one to keep asking about.

Where can you actually get each one—and what should you verify first?

Cream can be prescribed through some U.S. telehealth programs, while pellet insertion must happen in person. A pellet practice may still use telehealth for a consultation or follow-up, so “in-person insertion” does not mean every part of care must be in an office. Online access to either care pathway does not establish medical eligibility. Male Excel cream information; Hone treatment list; Testopel labeling.

Male Excel lists compounded testosterone cream. Its public pages provide enough detail to identify specific questions about pricing, formulation instructions, and renewal billing—not enough to certify an individual treatment plan, dispensing pharmacy, or clinician's performance. We checked its pages, not a patient account or a completed clinical intake. Male Excel cream page; pricing; terms.

Hone Health also lists testosterone cream among its men's treatments as of September 2026, alongside injections and troches. We haven't verified its current cream pricing first-hand, so confirm the medication cost, the membership tier, and what's included before you enroll rather than taking any published figure — ours or anyone's — as settled. Hone's treatment list.

Taurus Meds was not included as a cream or pellet option because this review did not verify either offering from the public materials checked. That is a limit of this comparison, not proof that the company's catalog can never change. There is no reason to stretch a pellet-versus-cream page to fit a different treatment format. Taurus public website.

Pellets require an in-person clinician for insertion. Look for urology, men's health, or endocrinology practices in your area, and use the question card above. Product identity, monitoring, complication management, and cost matter more than an advertisement saying only “pellet therapy.” Testopel labeling.

What is provider-stated, and what remains to be settled?

Sources checked 21 September 2026: Male Excel cream page, main pricing page, alternate pricing page, test-kit page, and terms. These are provider statements, not independent verification of care quality or a firsthand cancellation test.

Do not treat a short online assessment, a single result, or a paid kit as a diagnosis. The Endocrine Society calls for compatible symptoms or signs and consistently low testosterone, with repeat morning fasting testing and appropriate evaluation of the cause. Read the TRT blood-test guide before comparing lab-inclusive prices. Endocrine Society guideline.

Do telemedicine rules change the choice?

As of 21 September 2026, the DEA/HHS extension preserves certain federal telemedicine prescribing flexibilities through 31 December 2026. It does not waive all federal and state requirements or mean every provider may prescribe testosterone everywhere. The clinician must have the required authority, the prescription must be legitimate, and applicable telemedicine conditions must be met. DEA announcement.

That flexibility cannot perform a pellet insertion remotely. For cream, it still does not turn a questionnaire into guaranteed prescribing or remove any examination your clinician or state requires.

What did we actually verify?

This comparison separates product-label facts, published study findings, provider statements, and our editorial conclusions. The original contribution is the side-by-side commitment comparison, product-specific transfer table, conflicting-price and instruction record, billing-calendar calculations, and pre-payment worksheet—not a claim that we used either treatment or proved one universally better.

Verification date: 21 September 2026. We checked the accessible primary documents and official pages linked beside the claims. A public page confirms what an organization publishes; it does not confirm what happened in a patient appointment or checkout.

Sources we checked directly: the July 2025 Testopel and AndroGel 1.62% labels available through DailyMed; FDA compounding information and testosterone updates; the February 2025 and June 2026 regulatory announcements; the Endocrine Society's guideline page; Aetna's Testopel policy and CMS's A55057 record; the cited pellet studies' accessible published abstracts; the scrotal-cream pharmacokinetic paper; Biote's second-quarter 2026 filing; two Male Excel pricing pages, its cream page, test-kit page, and terms; Hone's treatment list; and the DEA telemedicine extension.

Confirmed from labels and official records: Testopel's strength, ingredients, stated duration, and adjustment limitation; the AndroGel 1.62%-specific 48–72-hour washout and transfer-study results; warnings about secondary exposure and fertility; the need for proper diagnosis and monitoring; the distinction between approved and compounded products; A55057's retirement; the public Asteria recall disclosure; and the federal extension's stated end date.

Provider-stated, not independently verified as your care experience: Male Excel's available product, pricing, application wording, membership descriptions, and refill process; Hone's listed cream offering; and any provider's description of support or clinical access. Conflicting public statements are identified rather than silently reconciled.

Not established by this review: a washout time or transfer-risk percentage for each compounded cream; a universal pellet-versus-cream winner; a national complete cash price; which Male Excel pricing page applies to a new patient; the final prescription, pharmacy, clinician, state access, or all-in bill an individual would receive. We did not perform a patient intake, laboratory visit, treatment trial, checkout, or cancellation test.

How this page was made: desk research and public-source verification by TRT Provider Guide, the independent decision resource for testosterone replacement therapy care. No clinician reviewed this version. We are not a clinic, pharmacy, laboratory, or medical practice. Our method is documented in How We Review TRT Providers. We update the "last verified" date only when we re-check the facts — not when we edit a sentence.

A note on safety: this page is educational information, not medical advice. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription and a clinician's supervision. Do not start, stop, or change a prescription based on this comparison. New chest pain or sudden trouble breathing needs emergency care; new one-sided leg pain or swelling needs prompt medical assessment, not a comparison page. Testopel safety information; AndroGel safety information.

What are the other common questions about pellets and cream?

The main tradeoff is treatment flexibility versus less daily work, not a universal winner on safety or cost. These answers keep the actual product and the limits of its evidence attached.

How long do testosterone pellets last?

The FDA label for Testopel says the effect ordinarily continues for three to four months and sometimes as long as six. The release isn't even across that window — roughly one-third of the dose is absorbed in the first month, one-quarter in the second, and one-sixth in the third. The timing of another insertion is a clinical decision, not a universal three-month subscription. Testopel label.

Can testosterone pellets be removed?

Removal may be necessary when a clinician needs to stop the effects of an implanted pellet, as the Testopel label explains. It requires clinical assessment and can involve another procedure; do not assume easy removal or immediate reversal of every effect. That's why anyone worried about reversibility should ask the implanting clinician — before the procedure — exactly how they handle a bad reaction or a level that comes back too high. Testopel label.

Is testosterone cream FDA-approved?

The compounded creams discussed here are not FDA-approved. FDA-approved testosterone gels are a separate product category; compounding can serve a legitimate medical need without making the product FDA-approved. FDA compounding guidance; FDA testosterone information.

Are testosterone pellets FDA-approved?

Testopel is. It's an approved 75 mg testosterone pellet for implantation under the skin. But the word “pellet” alone doesn't tell you the status, because compounded pellets are also used and are not FDA-approved. Ask which one your clinic implants. Testopel label; FDA compounding guidance.

Where do you apply testosterone cream?

It depends on the product, and this is not a place to guess. Follow the instructions for your actual prescription, and resolve any conflict with both the prescriber and pharmacist. AndroGel 1.62%'s shoulder-and-upper-arm instructions are not a universal rule for every gel or compounded cream. AndroGel 1.62% label; Male Excel's differing public directions.

Can testosterone cream transfer to my wife or children?

Topical testosterone can expose other people. The 280% and 6% measurements on this page are from separate approved gel studies, not measured transfer percentages for compounded cream. Product-specific precautions matter; pellets avoid the topical application-site pathway but have their own risks. AndroGel 1.62% label; Testopel label.

How many testosterone pellets does a man need?

That is a prescribing decision, not a number to pick from an article. Testopel's label and clinical studies describe different counts, but they do not establish the correct count for you. Ask for the product name, milligrams per pellet, total milligrams, and clinical rationale. Testopel label; McCullough et al.

How much do testosterone pellets cost?

Get a dated quote that specifies the product, medication or package price, insertion fee, expected procedures, lab work, and visits. A per-insertion price is not a full-year total, and a clinic may quote a package rather than charge per pellet. Use the worksheet above to compare actual offers on the same basis.

Does insurance cover pellets or cream?

Coverage depends on the exact product, indication, plan, documentation, and provider billing arrangement. Testopel has published payer policies, but CMS article A55057 is retired and should not be treated as a current nationwide promise. For cream, distinguish a cash-pay clinic's policy from your pharmacy benefit. Aetna policy; CMS A55057; Male Excel terms.

Do pellets or cream affect fertility?

Both can. Testosterone from outside the body can suppress sperm production in any format, and labeling warns that fertility impairment may be irreversible. A short serum-testosterone washout does not promise sperm recovery; see a urologist or reproductive urologist before choosing a format when fertility matters. AndroGel 1.62% labeling; Endocrine Society guideline.

Which is worse for hair loss—pellets or cream?

The evidence reviewed does not establish a reliable pellet-versus-cream ranking for hair loss. A scrotal-cream study measured increased DHT, but it did not measure comparative hair-loss outcomes or prove that a particular cream will cause more hair loss than pellets. If baldness runs in your family, raise it before you start either one. Iyer et al., 2017.

What happens if my hematocrit gets too high?

A clinician needs to assess it and decide whether treatment should be paused or changed and what else needs evaluation. AndroGel labeling calls for interruption when hematocrit is elevated, while an implanted supply makes treatment less flexible. Do not assume that a cream makes a high blood count resolve in two days. AndroGel 1.62% labeling; Testopel labeling.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool. It's educational and non-diagnostic—it helps organize your care-route choices and the questions to ask. It does not confirm low testosterone, determine eligibility, guarantee a prescription, or replace a clinician.

Sources

1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03b9c0b1-5884-11e4-8ed6-0800200c9a66
2. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee
3. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
4. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information
5. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
6. https://maleexcel.com/treatments/testosterone-cream/
7. https://maleexcel.com/treatments/hrt-costs/
8. https://hrt.maleexcel.com/pricing/
9. https://maleexcel.com/treatments/male-hormone-test/
10. https://maleexcel.com/terms-conditions/
11. https://onlinelibrary.wiley.com/doi/10.1111/andr.12357
12. https://pubmed.ncbi.nlm.nih.gov/22240203/
13. https://pubmed.ncbi.nlm.nih.gov/22403285/
14. https://pubmed.ncbi.nlm.nih.gov/19796052/
15. https://www.aetna.com/cpb/medical/data/300_399/0345.html
16. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=55057
17. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
18. https://www.hhs.gov/press-room/fda-requests-updates-testosterone-therapy-labeling.html
19. https://ir.biote.com/node/9131/html
20. https://help.honehealth.com/hc/en-us/articles/40162156169239-Hone-Health-Treatments-for-Men
21. https://taurusmeds.com/
22. https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care